NCT07080372View on ClinicalTrials.gov

Role of Early API in Accurately Differentiating Hepatocellular Carcinoma From Dysplastic Nodules in Cirrhotic Patients

Active, not recruitingOBSERVATIONAL
Enrollment

73

Participants

Timeline

Start Date

March 17, 2025

Primary Completion Date

September 1, 2025

Study Completion Date

February 28, 2026

Conditions
Dysplastic Nodule
Interventions
DIAGNOSTIC_TEST

assesment

This study aims to assess the role of early arterial phase in detecting and differentiating hepatocellular carcinoma from dysplastic nodules in chronic liver disease patients.

Trial Locations (1)

Unknown

Lahore General Hospital, Lahore

All Listed Sponsors
lead

Superior University

OTHER

NCT07080372 - Role of Early API in Accurately Differentiating Hepatocellular Carcinoma From Dysplastic Nodules in Cirrhotic Patients | Biotech Hunter | Biotech Hunter